California Public Employees Retirement System Olema Pharmaceuticals, Inc. Transaction History

California Public Employees Retirement System

$147 Billion
Q4 2024

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$21.15 - $36.14 $470,037 - $803,175	-22,224 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$27.81 - $53.64 $58,317 - $112,483	-2,097 Reduced 8.62%	22,224 $737,000
Q4 2020 Feb 02, 2021	BUY	$37.09 - $54.5 $902,065 - $1.33 Million	24,321 New	24,321 $1.17 Million

Others Institutions Holding OLMA

# of Institutions

162

Shares Held

71.9M

Call Options Held

251K

Put Options Held

6.7K

Bain Capital Life Sciences Investors, LLC Boston, MA

7.47M
Shares

$37.1 Million
11.76% of portfolio
Paradigm Biocapital Advisors LP New York, NY

7.3M
Shares

$36.3 Million
1.62% of portfolio
Bvf Inc San Francisco, CA

5.72M
Shares

$28.4 Million
1.25% of portfolio
Black Rock Inc. New York, NY

4M
Shares

$19.9 Million
0.0% of portfolio
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct

3.67M
Shares

$18.2 Million
0.05% of portfolio

View Full List

About Olema Pharmaceuticals, Inc.

Ticker OLMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,419,600
Market Cap $201M
Description
Olema Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for women's cancers. Its lead product candidate is OP-1250, an estrogen receptor (ER) antagonist and a selective ER degrader, which is in Phase 1/2 clinical trial for the treatment of recurrent, local...

More about OLMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.

Account